Bionano Genomics - Short Term - We look to Buy a break of 2.52 (stop at 2.25)
A break of yesterdays high would confirm bullish momentum. Posted a Double Bottom formation. The measured move target is 3.36. We look for gains to be extended today.
Our profit targets will be 3.13 and 3.30
Resistance: 2.50 / 3.00 / 4.00
Support: 2.00 / 1.70 / 1.50
Disclaimer –...
NASDAQ:BNGO
Although anticipating the start of an uptrend is no easy task, BNGO appears to finally be flat. The weeks leading up to the release of their 10-K should trade within the $3.00 - $4.00 range.
Current Options Positions
Short Calls - Strike 5.00 @ 1.21, 21-01-2022
Long Puts - Strike 2.00 @ 0. 05 , 21-01-2022
Short Calls - Strike 6.00 @0.21,...
NASDAQ:BNGO
BNGO has seen a steady decline over the last 8 months, you can read my past articles for the reasoning for this.
I believe we have now found our fair value of this company. the stock has been steadily holding the $3.00 line for the last one and a half weeks. It has as well been hovering around the oversold (30) on the RSI index. After bears have...
NASDAQ:BNGO
Well here we are...In my previous articles I have discussed the long term outlook and the short term outlook of BNGO. For the short term I have been right thus far. I want to talk about a few key factors in the last few days. Many investors have noticed price manipulation in stocks, BNGO included. There is a government investigation going on...
NASDAQ:BNGO
OANDA:US2000USD
BNGO down 5.63%...time to panic? Absolutely not, after the rally of small caps over the last two days, it is expected to see a pull back. Short term traders are locking in profits, and volatility was low today (only 5.6Mil). I expect to see the climb of BNGO through the holiday season.
Current Options Positions
Short Calls -...
NASDAQ:BNGO
Wow...What a tremendous day for BNGO. What's causing this sudden price spike? Are Investors pouring back into the company? Are we seeing a pump? BNGO has been oversold since November 22, 2021, finally it appears that the bleeding is over. Now investors should not get to excited, with the steady decline over the last 8 months, this could just be a...
NASDAQ:BNGO
As previously discussed, the long term outlook for BNGO is magnificent. With strong financial management and a revolutionary product, the company is set to break the BioTech industry. So why is the stock doing so poorly in the short term? The company has done very little in sales and has not marketed itself well. It is as simple as that; until the...
NASDAQ:BNGO
Has the down trend of BNGO finally come to an end? I am not one who believes in the reading of charts, I do understand the basis behind it though. The idea that humans exact in a certain way consistently, thus the charts should react in a similar way. I do not believe this is how people should invest, but I do understand the human tendency behind it....
NASDAQ:BNGO
As the BNGO struggles continue well into the third week of November 2021, what are the takeaways, and what should investors plan for the future?
The Underlying
The company is on track to do at least $15 million in revenue over each of the next five years, the EPS will be cut down to the break even point very soon. The company is currently holding...
NASDAQ:BNGO
What in the world is going on with BNGO? It seems as if no matter the news the stock goes down. For a company that is set to record their highest earnings ever, the stock movement does not reflect that. For smaller cap stocks this common, stock pumps, hedging, shorts; all play a role in the price. Why is the stock going down? Earlier this year...
BNGO has had its fair share of troubles in the last few months, the stock was pushed during the meme stock pump and dump phase earlier this year. What's next for BNGO?
BNGO is by no means a short term hold, the company has been working hard in the industry to provide advancements in OGM (Optical Genome Mapping). Although holding a $1.48B market cap, with a 52...
Bionano Genomics, it is in the field of gene sequencing.
The company`s product, Saphyr, uses optical genome mapping to help detect structural variations in gene sequencing.
Bionano recently acquired BioDiscovery for $100 million, which is a leader in clinical software production.
The acquisition may facilitate adoption of the Saphyr system, in $4 billion...
TICKER CODE: BNGO
Company Name: Bionano Genomics, Inc.
Industry: Healthcare | Biotechnology | USA
Position Proposed: BUY
Technical Analysis
1. Falling Wedge / Pennant (Forming)
2. Fibonacci Retracement at 0.786 ( Silver Zone)
3. RSI Reached OVERSOLD
4. 1st Take Profit will be at Fibonacci Expansion Safe Take Profit and Flagpole Length
Entry: NOW READY...
12.75 precious support, nice buyers pressure there so get your dips there.
get in, stay in, this will should print soon, BIG institutions behind this
those with patience... shall be rewarded
#no indicators needed straight price action baby
